Laura is an Associate, Pricing Data at PDCI. Her role includes preparation of Patented Medicine Prices Review Board (PMPRB) submissions, supporting pricing and market access assessments, price research, and assessing compliance with the PMPRB’s guidelines. In addition, Laura supports the market access team with coordinating and managing submissions to the Canadian Agency for Drugs and Technologies in Health (CADTH), Institut national d’excellence en santé et en services sociaux (INESSS), Federal/Provincial/Territorial (F/P/T) public drug plans and private drug plans.
Prior to joining PDCI in 2020, Laura worked in Natural Health Products and Cannabis consulting as a Project Manager supporting Health Canada submissions. Laura is currently pursuing her MBA specializing in Innovation Leadership. She looks forward to completing her degree in fall 2022.